Y Liu1, L E Rafkin2, D Matheson2, C Henderson3, D Boulware3, R E J Besser4, C Ferrara5, L Yu6, A K Steck6, P J Bingley7. 1. Division of Diabetes and Nutritional Sciences, King's College London, London, UK. 2. University of Miami Miller School of Medicine, Miami. 3. University of South Florida Health Informatics Institute, Tampa, FL, USA. 4. Department of Paediatrics, University of Oxford, Oxford, UK. 5. Division of Pediatric Endocrinology and Diabetes, University of California, San Francisco, CA. 6. Barbara Davis Center for Childhood Diabetes, University of Colorado School of Medicine, Aurora, CO, USA. 7. School of Clinical Sciences, University of Bristol, Bristol, UK.
Abstract
AIMS: To evaluate the feasibility of using self-collected capillary blood samples for islet autoantibody testing to identify risk in relatives of people with Type 1 diabetes. METHODS: Participants were recruited via the observational TrialNet Pathway to Prevention study, which screens and monitors relatives of people with Type 1 diabetes for islet autoantibodies. Relatives were sent kits for capillary blood collection, with written instructions, an online instructional video link and a questionnaire. Sera from capillary blood samples were tested for autoantibodies to glutamic acid decarboxylase, islet antigen-2, insulin and zinc transporter 8. 'Successful' sample collection was defined as obtaining sufficient volume and quality to provide definitive autoantibody results, including confirmation of positive results by repeat assay. RESULTS: In 240 relatives who returned samples, the median (range) age was 15.5 (1-49) years and 51% were male. Of these samples, 98% were sufficient for glutamic acid decarboxylase, islet antigen-2 and zinc transporter 8 autoantibody testing and 84% for insulin autoantibody testing and complete autoantibody screen. The upper 90% confidence bound for unsuccessful collection was 4.4% for glutamic acid decarboxylase, islet antigen-2 and/or zinc transporter 8 autoantibody assays, and 19.3% for insulin autoantibodies. Despite 43% of 220 questionnaire respondents finding capillary blood collection uncomfortable or painful, 82% preferred home self-collection of capillary blood samples compared with outpatient venepuncture (90% of those aged <8 years, 83% of those aged 9-18 years and 73% of those aged >18 years). The perceived difficulty of collecting capillary blood samples did not affect success rate. CONCLUSIONS: Self-collected capillary blood sampling offers a feasible alternative to venous sampling, with the potential to facilitate autoantibody screening for Type 1 diabetes risk.
AIMS: To evaluate the feasibility of using self-collected capillary blood samples for islet autoantibody testing to identify risk in relatives of people with Type 1 diabetes. METHODS:Participants were recruited via the observational TrialNet Pathway to Prevention study, which screens and monitors relatives of people with Type 1 diabetes for islet autoantibodies. Relatives were sent kits for capillary blood collection, with written instructions, an online instructional video link and a questionnaire. Sera from capillary blood samples were tested for autoantibodies to glutamic acid decarboxylase, islet antigen-2, insulin and zinc transporter 8. 'Successful' sample collection was defined as obtaining sufficient volume and quality to provide definitive autoantibody results, including confirmation of positive results by repeat assay. RESULTS: In 240 relatives who returned samples, the median (range) age was 15.5 (1-49) years and 51% were male. Of these samples, 98% were sufficient for glutamic acid decarboxylase, islet antigen-2 and zinc transporter 8 autoantibody testing and 84% for insulin autoantibody testing and complete autoantibody screen. The upper 90% confidence bound for unsuccessful collection was 4.4% for glutamic acid decarboxylase, islet antigen-2 and/or zinc transporter 8 autoantibody assays, and 19.3% for insulin autoantibodies. Despite 43% of 220 questionnaire respondents finding capillary blood collection uncomfortable or painful, 82% preferred home self-collection of capillary blood samples compared with outpatient venepuncture (90% of those aged <8 years, 83% of those aged 9-18 years and 73% of those aged >18 years). The perceived difficulty of collecting capillary blood samples did not affect success rate. CONCLUSIONS: Self-collected capillary blood sampling offers a feasible alternative to venous sampling, with the potential to facilitate autoantibody screening for Type 1 diabetes risk.
Authors: Jeffrey L Mahon; Jay M Sosenko; Lisa Rafkin-Mervis; Heidi Krause-Steinrauf; John M Lachin; Clinton Thompson; Polly J Bingley; Ezio Bonifacio; Jerry P Palmer; George S Eisenbarth; Joseph Wolfsdorf; Jay S Skyler Journal: Pediatr Diabetes Date: 2008-09-24 Impact factor: 4.866
Authors: Anette G Ziegler; Marian Rewers; Olli Simell; Tuula Simell; Johanna Lempainen; Andrea Steck; Christiane Winkler; Jorma Ilonen; Riitta Veijola; Mikael Knip; Ezio Bonifacio; George S Eisenbarth Journal: JAMA Date: 2013-06-19 Impact factor: 56.272
Authors: Liping Yu; David C Boulware; Craig A Beam; John C Hutton; Janet M Wenzlau; Carla J Greenbaum; Polly J Bingley; Jeffrey P Krischer; Jay M Sosenko; Jay S Skyler; George S Eisenbarth; Jeffrey L Mahon Journal: Diabetes Care Date: 2012-03-23 Impact factor: 19.112
Authors: Kimber M Simmons; Aimon K Alkanani; Kristen A McDaniel; Christopher Goyne; Dongmei Miao; Zhiyuan Zhao; Liping Yu; Aaron W Michels Journal: PLoS One Date: 2016-11-15 Impact factor: 3.240
Authors: Richard A Insel; Jessica L Dunne; Mark A Atkinson; Jane L Chiang; Dana Dabelea; Peter A Gottlieb; Carla J Greenbaum; Kevan C Herold; Jeffrey P Krischer; Åke Lernmark; Robert E Ratner; Marian J Rewers; Desmond A Schatz; Jay S Skyler; Jay M Sosenko; Anette-G Ziegler Journal: Diabetes Care Date: 2015-10 Impact factor: 19.112
Authors: Emily K Sims; Rachel E J Besser; Colin Dayan; Cristy Geno Rasmussen; Carla Greenbaum; Kurt J Griffin; William Hagopian; Mikael Knip; Anna E Long; Frank Martin; Chantal Mathieu; Marian Rewers; Andrea K Steck; John M Wentworth; Stephen S Rich; Olga Kordonouri; Anette-Gabriele Ziegler; Kevan C Herold Journal: Diabetes Date: 2022-04-01 Impact factor: 9.337
Authors: Lauren Marie Quinn; David Shukla; Sheila Margaret Greenfield; Tim Barrett; Joanna Garstang; Felicity Boardman; Ian Litchfield; Colin Dayan; Christine Gardner; Clair Connop; Amanda Lepley; Parth Narendran Journal: BMJ Open Diabetes Res Care Date: 2022-04
Authors: Polly J Bingley; Diane K Wherrett; Ann Shultz; Lisa E Rafkin; Mark A Atkinson; Carla J Greenbaum Journal: Diabetes Care Date: 2018-04 Impact factor: 19.112